5 things to know about the new obesity pill

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the makers of Wegovy and Mounjaro are seeking FDA approval for tablets.
KFGO

Factbox-Weight-loss drug developers line up to tap lucrative market as competition heats up

The weight-loss drug market is surging, with biotech firms racing to win share in a sector dominated by Novo Nordisk and Eli ...
STAT

Eli Lilly’s obesity pill helped patients maintain weight loss after switch from injections

Eli Lilly's obesity pill helped patients maintain weight loss after they switched from injectable drugs, outcomes that could ...

Lilly, Novo lock horns in India's obesity drug race

Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...

As India’s US$70 million obesity drug market bulges, so does price war

Pharmaceutical giants like Lilly and Nordisk are battling for dominance in India’s weight-loss market with price cuts and ...